Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression-Reference-Cited by-同舟云学术

Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression

Published:2022-04 Issue: Volume:618 Page:121682
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Di Filippo Leonardo Delello,Lobato Duarte Jonatas,Hofstätter Azambuja Juliana,Isler Mancuso Rubia,Tavares Luiz Marcela,Hugo Sousa Araújo Victor,Delbone Figueiredo Ingrid,Barretto-de-Souza Lucas,Miguel Sábio Rafael,Sasso-Cerri Estela,Martins Baviera Amanda,Crestani Carlos C.,Teresinha Ollala Saad Sara,Chorilli Marlus

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference81 articles.

1. Agnihotri, S.; Burrell, K. E.; Wolf, A.; Jalali, S.; Hawkins, C.; Rutka, J. T.; Zadeh, G. Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies. Archivum Immunologiae et Therapiae Experimentalis. Springer February 7, 2013, pp 25–41. https://doi.org/10.1007/s00005-012-0203-0.

2. Rock, K.; MCardle, O.; Forde, P. M.; Fitzpatrick, D.; O’Neill, B.; Faul, C. A clinical review of treatment outcomes in glioblastoma multiforme—the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival? | The British Journal of Radiology | Vol 85 https://www.birpublications.org/doi/full/10.1259/bjr/83796755 (accessed Feb 28, 2020).

3. Background, standard treatment paradigms, and supportive care considerations;Ellor;J. Law, Med. Ethics,2014

4. Nasal administration of cationic nanoemulsions as CD73-SiRNA delivery system for glioblastoma treatment: a new therapeutical approach;Azambuja;Mol. Neurobiol.,2020

5. Molecular determinants of malignant brain cancers: from intracellular alterations to invasion mediated by extracellular vesicles;Schiera;Int. J. Mol. Sci.,2017

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme;Journal of Biomaterials Science, Polymer Edition;2024-09-09

2. Advances in targeted nano-delivery of bevacizumab using nanoparticles: Current insights, innovations, and future perspectives;Journal of Drug Delivery Science and Technology;2024-09

3. Lipid Nanoparticles for Brain Tumor Theranostics: Challenges and Status;Bioconjugate Chemistry;2024-08-29

4. Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade;Archiv der Pharmazie;2024-07-29

5. Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-04